Jiang S - Search Results

1

Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza viruses.

Du L, Li Y, Gao J, Zhou Y, Jiang S. Du L, et al. Among authors: jiang s. Rev Med Virol. 2012 Nov;22(6):412-9. doi: 10.1002/rmv.1729. Epub 2012 Sep 14. Rev Med Virol. 2012. PMID: 22987727 Free PMC article. Review.

2

Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.

Neurath AR, Strick N, Li YY, Jiang S. Neurath AR, et al. Among authors: jiang s. AIDS Res Hum Retroviruses. 1993 Dec;9(12):1195-208. doi: 10.1089/aid.1993.9.1195. AIDS Res Hum Retroviruses. 1993. PMID: 8142138

3

Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV.

Neurath AR, Jiang S, Strick N, Lin K, Li YY, Debnath AK. Neurath AR, et al. Among authors: jiang s. Nat Med. 1996 Feb;2(2):230-4. doi: 10.1038/nm0296-230. Nat Med. 1996. PMID: 8574970

4

Blocking of CD4 cell receptors for the human immunodeficiency virus type 1 (HIV-1) by chemically modified bovine milk proteins: potential for AIDS prophylaxis.

Neurath AR, Debnath AK, Strick N, Li YY, Lin K, Jiang S. Neurath AR, et al. Among authors: jiang s. J Mol Recognit. 1995 Sep-Oct;8(5):304-16. doi: 10.1002/jmr.300080504. J Mol Recognit. 1995. PMID: 8619951

5

Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients.

Neurath AR, Strick N, Li YY, Lin K, Jiang S. Neurath AR, et al. Among authors: jiang s. Biologicals. 1999 Mar;27(1):11-21. doi: 10.1006/biol.1998.0169. Biologicals. 1999. PMID: 10441398

6

Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines.

He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, Jiang S. He Y, et al. Among authors: jiang s. J Immunol. 2004 Sep 15;173(6):4050-7. doi: 10.4049/jimmunol.173.6.4050. J Immunol. 2004. PMID: 15356154

7

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine.

He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, Jiang S. He Y, et al. Among authors: jiang s. Biochem Biophys Res Commun. 2004 Nov 12;324(2):773-81. doi: 10.1016/j.bbrc.2004.09.106. Biochem Biophys Res Commun. 2004. PMID: 15474494 Free PMC article.

8

Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus.

He Y, Zhou Y, Wu H, Kou Z, Liu S, Jiang S. He Y, et al. Among authors: jiang s. J Clin Microbiol. 2004 Nov;42(11):5309-14. doi: 10.1128/JCM.42.11.5309-5314.2004. J Clin Microbiol. 2004. PMID: 15528730 Free PMC article.

9

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.

He Y, Zhou Y, Siddiqui P, Jiang S. He Y, et al. Among authors: jiang s. Biochem Biophys Res Commun. 2004 Dec 10;325(2):445-52. doi: 10.1016/j.bbrc.2004.10.052. Biochem Biophys Res Commun. 2004. PMID: 15530413 Free PMC article.

10

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.

He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S. He Y, et al. Among authors: jiang s. Virology. 2005 Mar 30;334(1):74-82. doi: 10.1016/j.virol.2005.01.034. Virology. 2005. PMID: 15749124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,876 results

Search Page

Filters